Stay updated with breaking news from Specialty Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: Medios AG / Key word: Quarterly / Interim Statement/Quarter Results Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year...
Translation - the German version is authoritative Annual Report and ...
60 Degrees Pharma (Nasdaq: SXTP) will sponsor a study using tafenoquine, an FDA-approved malaria drug, to treat canine babesiosis, a tick-borne disease....
～Hidemasa's appointment bolsters Aculys' position as a leader in the field of CNS in Japan and Asia～
Vimian Group AB (publ) (OTCMKTS:VIMGF – Get Free Report) saw a large decrease in short interest in March. As of March 15th, there was short interest totalling 1,616,400 shares, a decrease of 22.9% from the February 29th total of 2,097,300 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently […]